Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Genomic engineering is the synthetic assembly of complete chromosomal DNA that is more or less derived from natural genomic sequences.
The global genome editing/genome engineering market is projected to USD 11.7 billion by 2026 from USD 5.1 billion in 2021, at a CAGR of 18.2 % between 2021 and 2028.
Recent improvements in this field have led to significant developments in the genome editing capabilities and it has enabled the modification of gene sequences of interest in a wide variety of cell types and model organisms and the shift from academics to clinical and diagnostic laboratories is primarily driven by improvements in gene editing technologies are some of the factors that have supported long-term expansion for Genome Editing/Genome Engineering Market.
The COVID-19 pandemic has prompted key pharmaceutical and biotechnology companies, as well as players in the genomic market, to invest in vaccine R&D. The rise in demand for vaccines and potential antiviral candidates has brought genome editing/engineering technologies to the forefront.
North America accounted for the largest share of this market, followed by Europe in 2020. The key factors helping in the growth of the market in North America include the development of gene therapy, increased use of GM crops, and a rise in the availability of research grants and funding in the US. The market in Canada is expected to witness growth in the coming years owing to various government initiatives and the intensification of genomics R&D (through GAPP) in the country.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 5.1 billion |
Growth Rate |
CAGR of 18.2% during the forecasting period, 2021-2026 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2026 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2026 |
Report Segmentation |
Product & services, technology, application, end user and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Thermo Fisher Scientific Inc., Merck KGaA and GenScript. |
Available Customization |
In addition to the market data for Genome Editing/Genome Engineering Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Genome Editing/Genome Engineering Market is segmented into product and services, technology, application, end user and region.